5.92
price up icon0.17%   0.010
after-market アフターアワーズ: 5.92
loading
前日終値:
$5.91
開ける:
$5.91
24時間の取引高:
928
Relative Volume:
0.05
時価総額:
$12.73M
収益:
$7.88M
当期純損益:
$-69.20M
株価収益率:
-3.235
EPS:
-1.83
ネットキャッシュフロー:
$-69.73M
1週間 パフォーマンス:
+2.96%
1か月 パフォーマンス:
-2.47%
6か月 パフォーマンス:
-49.68%
1年 パフォーマンス:
-59.86%
1日の値動き範囲:
Value
$5.91
$6.04
1週間の範囲:
Value
$5.52
$6.21
52週間の値動き範囲:
Value
$5.20
$15.60

Bolt Biotherapeutics Inc Stock (BOLT) Company Profile

Name
名前
Bolt Biotherapeutics Inc
Name
セクター
Healthcare (1160)
Name
電話
650-665-9295
Name
住所
900 CHESAPEAKE DRIVE, REDWOOD CITY
Name
職員
52
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
BOLT's Discussions on Twitter

BOLT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BOLT
Bolt Biotherapeutics Inc
5.92 12.73M 7.88M -69.20M -69.73M -1.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-01-06 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-03-02 開始されました Guggenheim Buy
2021-03-02 開始されました Morgan Stanley Overweight
2021-03-02 開始されました SVB Leerink Outperform
2021-03-02 開始されました Stifel Buy

Bolt Biotherapeutics Inc (BOLT) 最新ニュース

pulisher
Jun 12, 2025

Short Interest in Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Decreases By 91.6% - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Makes New Investment in Kuke Music Holding Limited (NYSE:KUKE) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Takes Position in Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Buys New Holdings in Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) - Defense World

Jun 11, 2025
pulisher
Jun 08, 2025

BOLT Trading Temporarily Halted as Company Awaits News | BOLT St - GuruFocus

Jun 08, 2025
pulisher
Jun 06, 2025

BOLT Trading Temporarily Halted as Company Awaits News | BOLT Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Bolt Biotherapeutics Announces Reverse Stock Split - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Bolt Biotherapeutics Announces 120 Reverse Stock Split Effective June 6, 2025 - MarketScreener

Jun 06, 2025
pulisher
Jun 05, 2025

Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews

Jun 05, 2025
pulisher
Jun 05, 2025

BOLT Announcement: Bronstein, Gewirtz and Grossman, LLC Announces Investor Securities Fraud Class Action Lawsuit Filed Against Bolt Biotherapeutics, Inc - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

BOLT Announcement: Bronstein, Gewirtz and Grossman, LLC Announces Investor Securities Fraud Class Action Lawsuit Filed Against Bolt Biotherapeutics, Inc. and Chance to Actively Participate - ACCESS Newswire

Jun 03, 2025
pulisher
May 28, 2025

Bolt Biotherapeutics Approves Key Governance Changes - TipRanks

May 28, 2025
pulisher
May 28, 2025

Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews

May 28, 2025
pulisher
May 22, 2025

Lake Street Capital Begins Coverage on Bolt Biotherapeutics (NASDAQ:BOLT) - Defense World

May 22, 2025
pulisher
May 20, 2025

Lake Street Initiates Coverage of Bolt Biotherapeutics (BOLT) with Buy Recommendation - Nasdaq

May 20, 2025
pulisher
May 20, 2025

BOLT: Lake Street Initiates Coverage on Bolt Biotherapeutics wit - GuruFocus

May 20, 2025
pulisher
May 20, 2025

BOLT: Lake Street Initiates Coverage on Bolt Biotherapeutics with Buy Rating | BOLT Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Lake Street Begins Coverage of Bolt Biotherapeutics (BOLT) with Bullish Outlook | BOLT Stock News - GuruFocus

May 20, 2025
pulisher
May 16, 2025

Leerink Partnrs Has Optimistic Outlook of BOLT Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

Stifel Nicolaus Lowers Bolt Biotherapeutics (NASDAQ:BOLT) Price Target to $1.00 - Defense World

May 15, 2025
pulisher
May 14, 2025

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 14, 2025
pulisher
May 13, 2025

BOLT Stock Target Price Revised to $1 Amid Recent Developments | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

BOLT: Stifel Lowers Price Target on Bolt Biotherapeutics, Mainta - GuruFocus

May 13, 2025
pulisher
May 13, 2025

BOLT Stock Target Price Revised to $1 Amid Recent Developments | BOLT Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Bolt Biotherapeutics Reports Q1 2025 Financial Results - TipRanks

May 13, 2025
pulisher
May 12, 2025

BOLT Exceeds Q1 Revenue Expectations with Higher Earnings | BOLT Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Bolt Biotherapeutics Inc.: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025
pulisher
May 12, 2025

Bolt Biotherapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Bolt Biotherapeutics Inc (BOLT) Q1 2025 Earnings: EPS of -$0.29 Beats Estimate, Revenue Surpasses Expectations at $1.2 Million - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Bolt Biotherapeutics, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 11, 2025

Bolt Biotherapeutics (BOLT) Expected to Announce Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 10, 2025

Biotech Alert: Searches spiking for these stocks today - Yahoo Finance

May 10, 2025
pulisher
May 08, 2025

BOLT: Surge in Interest for Bolt Biotherapeutics Amid Key Develo - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Bolt Biotherapeutics (BOLT) to Host Webcast on Clinical Study an - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Bolt Biotherapeutics (BOLT) to Host Webcast on Clinical Study and Financial Updates | BOLT Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 ... - Eagle-Tribune

May 08, 2025
pulisher
May 08, 2025

About Us - FinancialContent

May 08, 2025
pulisher
May 04, 2025

Bolt Biotherapeutics, Inc. (BOLT) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - ACCESS Newswire

May 04, 2025
pulisher
May 01, 2025

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025 - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Bolt Biotherapeutics amends bylaws, adjusts quorum requirement - Investing.com Australia

May 01, 2025
pulisher
Apr 30, 2025

Innovative Advances in Bolt Biotherapeutics (BOLT) Cancer Therap - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

New Cancer Treatment Breakthrough: Bolt Bio's Dual-Target Therapy Achieves Complete Response in Early Tests - Stock Titan

Apr 30, 2025
pulisher
Apr 29, 2025

Bolt Biotherapeutics amends bylaws, adjusts quorum requirement By Investing.com - Investing.com India

Apr 29, 2025
pulisher
Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 26, 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025 - The Manila Times

Apr 26, 2025
pulisher
Apr 25, 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Esca - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Bolt Biotherapeutics reports positive Phase 1 cancer trial results By Investing.com - Investing.com India

Apr 25, 2025
pulisher
Apr 25, 2025

Bolt Biotherapeutics Reports Positive Phase 1 Results for BDC-3042, Demonstrating Safety and Anti-Tumor Activity in Cancer Patients - Nasdaq

Apr 25, 2025
pulisher
Apr 25, 2025

Breakthrough Cancer Drug Achieves 80% Disease Control: Phase 1 Trial Reveals Promising NSCLC Results - Stock Titan

Apr 25, 2025

Bolt Biotherapeutics Inc (BOLT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Bolt Biotherapeutics Inc (BOLT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Quinn William P.
President, CEO and CFO
Dec 16 '24
Buy
0.50
2,500
1,241
41,272
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
大文字化:     |  ボリューム (24 時間):